Cited by 279Virus-based gene therapy researchRNA Interference and Gene DeliveryRNA Research and Splicing

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Enhanced Expression of Transgenes from Adeno-Associated Virus Vectors with the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element: Implications for Gene Therapy

Loeb, Jonathan E., Cordier, Wendy S., Harris, Matthew E., Weitzman, Matthew D., Hope, Thomas J.·1999·Human Gene Therapy

Open this paper in CoChat — free account

Abstract

The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) evolved to stimulate the expression of intronless viral messages. To determine whether this ability to enhance expression could be useful in nonviral and heterologous viral gene delivery systems, we analyzed the ability of the WPRE to elevate the expression of a cDNA encoding the green fluorescent protein (GFP) in these contexts. We find that the WPRE can stimulate the expression of GFP when the gene is delivered by transfection or transduction with recombinant adeno-associated virus (AAV). Enhancement occurred both during transient expression and when the gene is stably incorporated into the genome of target cells. This enhancement required that the WPRE be located in cis within the GFP message, and was observed in both transformed cell lines and primary human fibroblasts. These results demonstrate that the WPRE will be an effective tool for increasing the long-term expression of transgenes in gene therapy.

Integrity signals

Registry

Crossref · 10.1089/10430349950016942

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

THE GREEN FLUORESCENT PROTEIN
Tsien, R. Y. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.509 · Cited by 6,178
Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
The HIV-1 Rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280
Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,030
Self-citation
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 913
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L. A., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R. P., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 546
Self-citation
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490

Show all 35 references

Research works printed but not linked: 2

BUCHMAN A.R., 1988, Mol. Cell. Biol., 8, 4395, 10.1128/MCB.8.10.4395 · DOI
FLOTTE T.R., 1995, Gene Ther., 2, 357

Sorted by citations

Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Thy1-GCaMP6 transgenic mice for neuronal population imaging in vivo
Dana, H., Chen, T.-W., Hu, A., Shields, B. C., Guo, C., Looger, L. L., Kim, D. S., & Svoboda, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108697 · Cited by 574
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 630
Self-citation
High-Level Transduction and Gene Expression in Hematopoietic Repopulating Cells Using a Human Imunodeficiency Virus Type 1-Based Lentiviral Vector Containing an Internal Spleen Focus Forming Virus Promoter
Demaison, C., Parsley, K. L., Brouns, G. S., Scherr, M., Battmer, K., Kinnon, C., Grez, M., & Thrasher, A. J. (2002) · Human Gene Therapy · doi:10.1089/10430340252898984 · Cited by 486
Drug Targeting to the Brain
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 450
Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression
Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420
Gene therapy with brain-derived neurotrophic factor as a protection: Retinal ganglion cells in a rat glaucoma model
Martin, K. R. G., Quigley, H. A., Zack, D. J., Levkovitch-Verbin, H., Kielczewski, J., Valenta, D., Baumrind, L., Pease, M. E., Klein, R. L., & Hauswirth, W. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1332 · Cited by 362
Drug Targeting to the Brain
de Boer, A. G., & Gaillard, P. J. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 355
Gene Therapy: Promises and Problems
Pfeifer, A., & Verma, I. M. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.177 · Cited by 345
Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications
Wang, H. B., Mullins, M. E., Cregg, J. M., Hurtado, A., Oudega, M., Trombley, M. T., & Gilbert, R. J. (2008) · Journal of Neural Engineering · doi:10.1088/1741-2560/6/1/016001 · Cited by 313
Dopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra
Klein, R. L., King, M. A., Hamby, M. E., & Meyer, E. M. (2002) · Human Gene Therapy · doi:10.1089/10430340252837206 · Cited by 212
Recombinant AAV-mediated gene delivery to the central nervous system
Tenenbaum, L., Chtarto, A., Lehtonen, E., Velu, T. J., Brotchi, J., & Levivier, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.506 · Cited by 213
Retroviral Vectors for High-Level Transgene Expression in T Lymphocytes
Engels, B., Çam, H., Schüler, T., Indraccolo, S., Gladow, M., Baum, C., Blankenstein, T. J. F., & Uckert, W. (2003) · Human Gene Therapy · doi:10.1089/104303403322167993 · Cited by 202
Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons
Choi, J.-H., Yu, N.-K., Baek, G.-C., Bakes, J., Seo, D., Nam, H. J., Baek, S. H., Lim, C.-S., Lee, Y.-S., & Kaang, B.-K. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-17 · Cited by 188
Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors
Schambach, A., Wodrich, H., Hildinger, M., Bohne, J., Kräusslich, H.-G., & Baum, C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0191 · Cited by 194
Synaptic Specificity and Application of Anterograde Transsynaptic AAV for Probing Neural Circuitry
Zingg, B., Peng, B., Huang, J., Tao, H. W., & Zhang, L. I. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2158-19.2020 · Cited by 197
Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.
Mah, C., Fraites, T. J., Zolotukhin, I., Song, S.-H., Flotte, T., Dobson, J., Batich, C., & Byrne, B. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0636 · Cited by 180
Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in Liver
Wang, L., Nichols, T. C., Read, M. S., Bellinger, D. A., & Verma, I. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0031 · Cited by 176
Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Papadakis, E. D., Nicklin, S. A., Baker, A. H., & White, S. J. (2004) · Current Gene Therapy · doi:10.2174/1566523044578077 · Cited by 175
Evasion of Immune Responses to Introduced Human Acid α-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II
Franco, L. M., Sun, B., Yang, X., Bird, A., Zhang, H., Schneider, A., Brown, T. T., Young, S. P., Clay, T. M., Amalfitano, A., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.024 · Cited by 170
Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain
Paterna, J.-C., Moccetti, T., Mura, A., Feldon, J., & Büeler, H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301221 · Cited by 189
Dose and Promoter Effects of Adeno-Associated Viral Vector for Green Fluorescent Protein Expression in the Rat Brain
Klein, R. L., Hamby, M. E., Gong, Y., Hirko, A. C., Wang, S., Hughes, J. A., King, M. A., & Meyer, E. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7942 · Cited by 169
Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease
de Almeida, L. P., Zala, D., Aebischer, P., & Déglon, N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0388 · Cited by 163
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00232-3 · Cited by 149
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Tenenbaum, L., Lehtonen, E., & Monahan, P. E. (2003) · Current Gene Therapy · doi:10.2174/1566523034578131 · Cited by 146
Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord
Eaton, M. J., Blits, B., Ruitenberg, M. J., Verhaagen, J., & Oudega, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301814 · Cited by 146
Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression
Schambach, A., Bohne, J., Baum, C., Hermann, F. G., Egerer, L., von Laer, D., & Giroglou, T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302698 · Cited by 145
Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic Cells
Yam, P. Y., Li, S., Wu, J. C., Hu, J. X., Zaia, J. A., & Yee, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0558 · Cited by 142
Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor
Blits, B., Carlstedt, T. P., Ruitenberg, M. J., DEWINTER, F., HERMENS, W., Dijkhuizen, P. A., CLAASENS, J., Eggers, R., VANDERSLUIS, R., & Tenenbaum, L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.014 · Cited by 139
Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation
Yoshimura, H., Shibata, S. B., Ranum, P. T., & Smith, R. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21233-z · Cited by 127
Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord
Ruitenberg, M. J., Plant, G. W., Christensen, C. L., Blits, B., Niclou, S. P., Harvey, A. R., Boer, G. J., & Verhaagen, J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301626 · Cited by 124
Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function
Blits, B., Oudega, M., Boer, G. J., Bunge, M. B., & Verhaagen, J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00970-3 · Cited by 122
HIV-1 Vpr—a still “enigmatic multitasker”
Guenzel, C. A., Hérate, C., & Bénichou, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00127 · Cited by 137
Adenoviral-Mediated, High-Level, Cell-Specific Transgene Expression: A SYN1-WPRE Cassette Mediates Increased Transgene Expression with No Loss of Neuron Specificity
Glover, C. P. J., Bienemann, A. S., Heywood, D. J., Cosgrave, A. S., & Uney, J. B. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0588 · Cited by 120
Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: A comparison with lentiviral vectors
Harvey, A. R., Kamphuis, W., Eggers, R., Symons, N. A., Blits, B., Niclou, S., Boer, G. J., & Verhaagen, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1168 · Cited by 114
Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter
Sun, B., Zhang, H., Franco, L. M., Brown, T. T., Bird, A., Schneider, A., & Koeberl, D. D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.012 · Cited by 112
Methods for Gene Transfer to the Central Nervous System
Kantor, B., Bailey, R. M., Wimberly, K., Kalburgi, S. N., & Gray, S. J. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800149-3.00003-2 · Cited by 109
Nanoparticle-based technologies for retinal gene therapy
Adijanto, J., & Naash, M. I. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.028 · Cited by 107
CAR-T cell potency: from structural elements to vector backbone components
Mazinani, M., & Rahbarizadeh, F. (2022) · Biomarker Research · doi:10.1186/s40364-022-00417-w · Cited by 111
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors
Higashimoto, T., Urbinati, F., Perumbeti, A., Jiang, G., Zarzuela, A., Chang, L.-J., Kohn, D. B., & Malik, P. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302979 · Cited by 101
Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain
Fitzsimons, H. L., Bland, R. J., & During, M. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00227-x · Cited by 102
Gene therapy: targeting the myocardium
Lyon, A. R., Sato, M., Hajjar, R. J., Samulski, R. J., & Harding, S. E. (2007) · Heart · doi:10.1136/hrt.2007.116483 · Cited by 98
Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system
Rahim, A. A., Wong, A. M. S., Hoefer, K., Buckley, S. M. K., Mattar, C. N. Z., Cheng, S. H., Chan, J. K. Y., Cooper, J. D., & Waddington, S. N. (2011) · The FASEB Journal · doi:10.1096/fj.11-182311 · Cited by 101
Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice
Helwig, M., Klinkenberg, M., Rusconi, R., Musgrove, R. E., Majbour, N. K., El‐Agnaf, O. M. A., Ulusoy, A., & Monte, D. A. D. (2015) · Brain · doi:10.1093/brain/awv376 · Cited by 97
Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury
Ulusoy, A., Musgrove, R. E., Rusconi, R., Klinkenberg, M., Helwig, M., Schneider, A., & Monte, D. A. D. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0198-y · Cited by 91
Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo
Tolmachova, T., Tolmachov, O. E., Barnard, A. R., Silva, S. R. D., Lipinski, D. M., Walker, N. J., MacLaren, R. E., & Seabra, M. C. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1006-4 · Cited by 92
Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord
Hill, C. E., Hurtado, A., Blits, B., Bahr, B. A., Wood, P. M., Bunge, M. B., & Oudega, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05771.x · Cited by 90
Recombinant Adeno-Associated Viral Vectors in the Nervous System
Burger, C., Nash, K., & Mandel, R. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.781 · Cited by 110
Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer
Park, J., Murray, G. J., Limaye, A., Quirk, J. M., Gelderman, M. P., Brady, R. O., & Qasba, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0537900100 · Cited by 88
AAV vector development, back to the future
Suárez-Amarán, L., Song, L., Tretiakova, A. P., Mikhail, S., & Samulski, R. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.064 · Cited by 98
Central Pro-opiomelanocortin Gene Delivery Results in Hypophagia, Reduced Visceral Adiposity, and Improved Insulin Sensitivity in Genetically Obese Zucker Rats
Li, G., Mobbs, C. V., & Scarpace, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1951 · Cited by 88
Adeno-associated Virus Vector Serotypes Mediate Sustained Correction of Bilirubin UDP Glucuronosyltransferase Deficiency in Rats
Seppen, J., Bakker, C., de Jong, B., Kunne, C., van den Oever, K., Vandenberghe, K., de Waart, R. D., Twisk, J., & Bosma, P. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.014 · Cited by 87
Thy1 transgenic mice expressing the red fluorescent calcium indicator jRGECO1a for neuronal population imaging in vivo
Dana, H., Novák, O., Guardado-Montesino, M., Fransen, J. W., Hu, A., Borghuis, B. G., Guo, C., Kim, D. S., & Svoboda, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205444 · Cited by 87
Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)
Kingsman, S. M., Mitrophanous, K., & Olsen, J. C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302417 · Cited by 84
Adenovirus Ubiquitin-Protein Ligase Stimulates Viral Late mRNA NuclearExport
Woo, J. L., & Berk, A. J. (2006) · Journal of Virology · doi:10.1128/jvi.01725-06 · Cited by 86
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency
Kang, M. H., van Lieshout, L. P., Xu, L., Domm, J. M., Vadivel, A., Renesme, L., Mühlfeld, C., Hurskainen, M., Mižíková, I., Pei, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17577-8 · Cited by 85
CRM1-Dependent Function of a cis-Acting RNA Export Element
Popa, I., Harris, M. E., Donello, J. E., & Hope, T. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2057-2067.2002 · Cited by 82
Self-citation
WPRE-mediated enhancement of gene expression is promoter and cell line specific
Klein, R., Ruttkowski, B., Knapp, E., Salmons, B., Günzburg, W. H., & Hohenadl, C. (2006) · Gene · doi:10.1016/j.gene.2005.12.018 · Cited by 81
Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury
Ruitenberg, M. J., Blits, B., Dijkhuizen, P. A., Beek, E. T. T., Bakker, A., van Heerikhuize, J. J., Pool, C. W., Hermens, W. T. J., Boer, G. J., & Verhaagen, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.018 · Cited by 80
Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis
Jackson, K. L., Dayton, R. D., Orchard, E. A., Ju, S., Ringe, D., Petsko, G. A., Maquat, L. E., & Klein, R. L. (2014) · Gene Therapy · doi:10.1038/gt.2014.101 · Cited by 76
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
Nieuwenhuis, B., Laperrousaz, E., Tribble, J. R., Verhaagen, J., Fawcett, J. W., Martin, K. R. G., Williams, P. A., & Osborne, A. (2023) · Gene Therapy · doi:10.1038/s41434-022-00380-z · Cited by 81
Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea
Stone, I. M., Lurie, D. I., Kelley, M. W., & Poulsen, D. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.005 · Cited by 75
Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo
Liu, B., Paton, J. F. R., & Kasparov, S. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-49 · Cited by 74
Optimal Design of a Single Recombinant Adeno-associated Virus Derived from Serotypes 1 and 2 to Achieve More Tightly Regulated Transgene Expression from Nonhuman Primate Muscle
Chenuaud, P., Larcher, T., Rabinowitz, J. E., Provost, N., Joussemet, B., Bujard, H., Samulski, R. J., Moullier, P., & Favre, D. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.12.015 · Cited by 74
Long-term Amelioration of Feline Mucopolysaccharidosis VI After AAV-mediated Liver Gene Transfer
Cotugno, G., Annunziata, P., Tessitore, A., O’Malley, T. M., Capalbo, A., Faella, A., Bartolomeo, R., O’Donnell, P., Wang, P., Russo, F., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.257 · Cited by 76
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice
Migdalska‐Richards, A., Węgrzynowicz, M., Rusconi, R., Deangeli, G., Monte, D. A. D., Spillantini, M. G., & Schapira, A. H. V. (2017) · Brain · doi:10.1093/brain/awx221 · Cited by 76
Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system
Ruitenberg, M. J., Eggers, R., Boer, G. J., & Verhaagen, J. (2002) · Methods · doi:10.1016/s1046-2023(02)00222-0 · Cited by 75
Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration
Homs, J., Ariza, L., Pagès, G., Udina, E., Navarro, X., Chillón, M., & Bosch, A. (2011) · Gene Therapy · doi:10.1038/gt.2011.7 · Cited by 67
Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications
Schön, C., Biel, M., & Michalakis, S. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.009 · Cited by 72
[27] Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors
Rohll, J. B., Mitrophanous, K. A., Martin‐Rendon, E., Ellard, F. M., Radcliffe, P. A., Mazarakis, N. D., & Kingsman, S. M. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46072-7 · Cited by 68
Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity
Wilsey, J. T., Zolotukhin, S., Prima, V., & Scarpace, P. J. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00193.2003 · Cited by 67
Helper‐dependent adenoviral gene therapy mediates long‐term correction of the clotting defect in the canine hemophilia A model
McCORMACK, W. M., Seiler, M. P., Bertin, T., UBHAYAKAR, K., Palmer, D. J., Ng, P., Nichols, T. C., & Lee, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01901.x · Cited by 67
Leptin-Induced Leptin Resistance Reveals Separate Roles for the Anorexic and Thermogenic Responses in Weight Maintenance
Scarpace, P. J., Matheny, M. E., Zhang, Y., Shek, E. W., Prima, V., Zolotukhin, S., & Tümer, N. (2002) · Endocrinology · doi:10.1210/endo.143.8.8966 · Cited by 67
Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain
Fitzsimons, H. L., McKenzie, J., & During, M. J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301582 · Cited by 66
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence
Romeo-Guitart, D., Forés, J., Herrando-Grabulosa, M., Valls, R., Leiva-Rodríguez, T., Galea, E., González-Pérez, F., Navarro, X., Petegnief, V., Bosch, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19767-3 · Cited by 71
Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
Mitsios, A., Dubis, A. M., & Moosajee, M. (2018) · Therapeutic Advances in Ophthalmology · doi:10.1177/2515841418817490 · Cited by 62
Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats
Scarpace, P. J., Matheny, M. E., Zhang, Y., Tümer, N., Frase, C. D., Shek, E. W., Hong, B., Prima, V., & Zolotukhin, S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00003-5 · Cited by 62
Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice
Gholizadeh, S., Tharmalingam, S., MacAldaz, M. E., & Hampson, D. R. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.076 · Cited by 61
Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina
Patrício, M. I., Barnard, A. R., Orlans, H. O., McClements, M. E., & MacLaren, R. E. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.12.006 · Cited by 59
Long-Term Correction of Ornithine Transcarbamylase Deficiency by WPRE-Mediated Overexpression Using a Helper-Dependent Adenovirus
Mian, A. I., McCormack, W. M., Mane, V. P., Kleppe, S., Ng, P., Finegold, M. J., O’Brien, W. E., Rodgers, J. R., Beaudet, A. L., & Lee, B. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.036 · Cited by 59
Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) VectorPreprint
Barnard, A. R., Groppe, M., & MacLaren, R. E. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017293 · Cited by 62
Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells
Dreismann, A. K., McClements, M. E., Barnard, A. R., Orhan, E., Hughes, J. P., Lachmann, P. J., & MacLaren, R. E. (2021) · Gene Therapy · doi:10.1038/s41434-021-00239-9 · Cited by 58
Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model
Huda, F., Konno, A., Matsuzaki, Y., Goenawan, H., Miyake, K., Shimada, T., & Hirai, H. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.32 · Cited by 58
Adeno-Associated Virus-Mediated Rhodopsin Replacement Provides Therapeutic Benefit in Mice with a Targeted Disruption of the Rhodopsin Gene
Palfi, A., Millington‐Ward, S., Chadderton, N., O’Reilly, M., Goldmann, T., Humphries, M. M., Li, T., Wolfrum, U., Humphries, P., Kenna, P. F., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.119 · Cited by 56
The substituted aspartate analogue l-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3
Esslinger, C. S., Agarwal, S. R., Gerdes, J. M., Wilson, P. A., Davis, E. S., Awes, A. N., O’Brien, E. M., Mavencamp, T., Koch, H. P., Poulsen, D. J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.009 · Cited by 56
Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells
Mähönen, A. J., Airenne, K. J., Purola, S., Peltomaa, E., Kaikkonen, M. U., Riekkinen, M. S., Heikura, T., Kinnunen, K., Roschier, M. M., Wirth, T., et al. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.05.022 · Cited by 56
Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery
Boulis, N. M., Noordmans, A. J., Song, D. K., Imperiale, M. J., Rubin, A. D., Leone, P., During, M. J., & Feldman, E. L. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.025 · Cited by 56
Optimization of transgene expression at the posttranscriptional level in neural cells: implications for gene therapy
Brun, S., Biguet, N. F., & Mallet, J. J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00097-2 · Cited by 54
Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats
Li, G., Zhang, Y., Wilsey, J. T., & Scarpace, P. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1943-8 · Cited by 54
Therapeutic Levels of Factor IX Expression Using a Muscle-Specific Promoter and Adeno-Associated Virus Serotype 1 Vector
Liu, Y.-L., Mingozzi, F., Rodriguez-Colon, S. M., Joseph, S. O., Dobrzynski, E., Suzuki, T., High, K. A., & Herzog, R. W. (2004) · Human Gene Therapy · doi:10.1089/1043034041648453 · Cited by 57
Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B
Harding, T., Koprivnikar, K., Tu, G., Zayek, N., Lew, S., Subramanian, A., Sivakumaran, A., Frey, D., Ho, K. I., VanRoey, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302142 · Cited by 53
Rapid Neurofibrillary Tangle Formation after Localized Gene Transfer of Mutated Tau
Klein, R. L., Lin, W.-L., Dickson, D. W., Lewis, J. M., Hutton, M. L., Duff, K., Meyer, E. M., & King, M. A. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63124-0 · Cited by 52
Imaging the response of the retina to electrical stimulation with genetically encoded calcium indicators
Weitz, A. C., Behrend, M. R., Lee, N. S., Klein, R. L., Chiodo, V. A., Hauswirth, W. W., Humayun, M. S., Weiland, J. D., & Chow, R. H.-P. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00852.2012 · Cited by 51
Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair
Sweeney, C. L., Pavel-Dinu, M., Choi, U., Brault, J., Liu, T., Koontz, S. M., Li, L., Theobald, N., Lee, J., Bello, E. A., et al. (2021) · Gene Therapy · doi:10.1038/s41434-021-00251-z · Cited by 51
Promising and delivering gene therapies for vision loss
Carvalho, L. S., & Vandenberghe, L. H. (2014) · Vision Research · doi:10.1016/j.visres.2014.07.013 · Cited by 51
Woodchuck post‐transcriptional element induces nuclear export of myotonic dystrophy 3′ untranslated region transcripts
Mastroyiannopoulos, N. P., Feldman, M. L., Uney, J. B., Mahadevan, M. S., & Phylactou, L. A. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400390 · Cited by 49
Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside
Xu, L., Yao, S., Ding, Y. E., Xie, M., Feng, D., Sha, P., Tan, L., Bei, F., & Yao, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05661-2 · Cited by 48
Enhanced Gene Transfer Efficiency in the Murine Striatum and an Orthotopic Glioblastoma Tumor Model, Using AAV-7- and AAV-8-Pseudotyped Vectors
Harding, T. C., Dickinson, P. J., Roberts, B. N., Yendluri, S., Gonzalez-Edick, M., Lecouteur, R. A., & Jooss, K. U. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.807 · Cited by 45
Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors
Xu, Z., Mizuguchi, H., Mayumi, T., & Hayakawa, T. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00078-3 · Cited by 43

Authors: Loeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J.
Affiliations: Salk Institute for Biological Studies (US)
ORCID: Weitzman, Matthew D.
Hope, Thomas J.
Venue: Human Gene Therapy
Publisher: SAGE Publications
Published: 1999-09-20
Volume: 10
Issue: 14
Pages: 2295-2305
ISSN: 1043-0342 (ISSN-L)
1557-7422
DOI: 10.1089/10430349950016942
OpenAlex: W2142334980
Cited by: 279
References: 35
Citations by year: 2026: 3 · 2025: 7 · 2024: 18 · 2023: 8 · 2022: 10 · 2021: 15 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 10 · 2014: 11 · 2013: 6 · 2012: 6
FWCI: 5.23
Type: journal article
Language: en
Open access: closed
Licence: www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
Locations: Human Gene Therapy (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords: woodchuck hepatitis virus, adeno-associated virus vectors, green fluorescent protein, gene therapy, cis-acting regulation, stable transfection, transduction, human fibroblasts, long-term transgene expression
MeSH terms: Dependovirus, Cell Line, Flow Cytometry, Genetic Vectors, Humans, Luminescent Proteins, Regulatory Sequences, Nucleic Acid, RNA Processing, Post-Transcriptional, RNA, Viral, Blotting, Western, Gene Expression Regulation, Viral, Hepatitis B Virus, Woodchuck, Gene Transfer Techniques, Transgenes, Green Fluorescent Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Enhanced Expression of Transgenes from Adeno-Associated Virus Vectors with the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element: Implications for Gene Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks